A Novel Approach to Overcome Cisplatin Resistance in Ovarian Cancer: Revealing the Synergistic Potential of Quercetin-Loaded Solid Lipid Nanoparticles
QU-SLN and cisplatin combination enhances the therapeutic response in cisplatin-resistant OC cells. By reducing cell proliferation, promoting apoptosis, and downregulating drug resistance genes, QU-SLN might present a promising strategy to improve treatment outcomes for OC patients resistant to cisplatin.
Authors
- Mojtaba Rashidi (ORCID: https://orcid.org/0000-0003-4311-6137)
- Masoumeh Shamsi
- Mahdi Hatami (ORCID: https://orcid.org/0000-0002-7810-5780)
- Azam Khedri (ORCID: https://orcid.org/0000-0001-9623-1054)
- Hossien Babaahmadi-Rezaei
Institutions
- Ahvaz Jundishapur University of Medical Sciences (IR)
Publication Details
- Journal
- Iranian Biomedical Journal
- Published
- 2025-01-01
- DOI
- https://doi.org/10.61882/ibj.4543
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ahvaz Jundishapur University of Medical Sciences